Total Payments
$11,788
2024 Payments
$1,246
Companies
31
Transactions
316
Medicare Patients
8,559
Medicare Billing
$677,704
Payment Breakdown by Category
Food & Beverage$7,941 (67.4%)
Travel$3,847 (32.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,941 | 300 | 67.4% |
| Travel and Lodging | $3,847 | 16 | 32.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corindus Inc. | $2,905 | 20 | $0 (2018) |
| ABIOMED | $2,545 | 21 | $0 (2024) |
| Boston Scientific Corporation | $2,058 | 50 | $0 (2024) |
| Amgen Inc. | $576.73 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $461.03 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $393.49 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $372.82 | 37 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $369.39 | 22 | $0 (2024) |
| ATRICURE, INC. | $298.87 | 4 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $279.11 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,246 | 35 | Boston Scientific Corporation ($307.91) |
| 2023 | $1,384 | 67 | Boston Scientific Corporation ($188.73) |
| 2022 | $1,379 | 73 | Amgen Inc. ($235.02) |
| 2021 | $789.51 | 44 | Teva Pharmaceuticals USA, Inc. ($221.07) |
| 2020 | $223.17 | 9 | Boston Scientific Corporation ($191.51) |
| 2019 | $461.05 | 14 | Boston Scientific Corporation ($365.34) |
| 2018 | $4,585 | 47 | ABIOMED ($2,182) |
| 2017 | $1,720 | 27 | Corindus Inc. ($1,257) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Genetic Disease | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Rare Disease | ||||||
| 09/10/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Medical Device | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Rare Disease | ||||||
| 08/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology | ||||||
| 08/12/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Genetic Disease | ||||||
| 08/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $39.82 | General |
| Category: General - Stents_IC | ||||||
| 07/25/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.35 | General |
| Category: Medical Device | ||||||
| 07/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiology | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/17/2024 | Teleflex LLC | MANTA (Device) | Food and Beverage | In-kind items and services | $97.23 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $45.75 | General |
| Category: General - Stents_IC | ||||||
| 05/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiology | ||||||
| 04/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $149.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $38.30 | General |
| Category: AVVIGO_IC | ||||||
| 03/26/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Genetic Disease | ||||||
| 03/25/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $151.42 | General |
| Category: Lithoplasty | ||||||
| 03/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardiology | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,686 | 2,064 | $465,549 | $116,174 |
| 2022 | 19 | 1,129 | 1,445 | $365,276 | $92,717 |
| 2021 | 32 | 2,409 | 3,364 | $694,011 | $197,235 |
| 2020 | 44 | 3,335 | 4,886 | $937,372 | $271,578 |
Total Patients
8,559
Total Services
11,759
Medicare Billing
$677,704
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 269 | $39,543 | $14,645 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 158 | $36,498 | $13,799 | 37.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 93 | 98 | $73,402 | $12,930 | 17.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 222 | $35,298 | $12,622 | 35.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 83 | 90 | $40,410 | $11,388 | 28.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 18 | 24 | $44,304 | $8,796 | 19.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 37 | 37 | $36,186 | $6,641 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $24,576 | $6,462 | 26.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 117 | 118 | $25,252 | $5,849 | 23.2% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 13 | 13 | $24,674 | $5,329 | 21.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 46 | $10,396 | $4,096 | 39.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 55 | 55 | $22,440 | $2,889 | 12.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 213 | 273 | $19,656 | $2,614 | 13.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 316 | 372 | $9,672 | $2,262 | 23.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $7,320 | $1,914 | 26.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 21 | $4,242 | $1,242 | 29.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 61 | 61 | $4,209 | $900.44 | 21.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 63 | 63 | $2,835 | $625.21 | 22.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 11 | 12 | $1,488 | $384.17 | 25.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 18 | 18 | $1,278 | $349.20 | 27.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 20 | 20 | $1,300 | $320.33 | 24.6% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 12 | 15 | $570.00 | $118.30 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 309 | $45,423 | $18,543 | 40.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 91 | 99 | $74,151 | $14,325 | 19.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 213 | $33,867 | $11,184 | 33.0% |
About Dr. John Baker, MD
Dr. John Baker, MD is a Cardiovascular Disease healthcare provider based in Jackson, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003801796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Baker, MD has received a total of $11,788 in payments from pharmaceutical and medical device companies, with $1,246 received in 2024. These payments were reported across 316 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,941).
As a Medicare-enrolled provider, Baker has provided services to 8,559 Medicare beneficiaries, totaling 11,759 services with total Medicare billing of $677,704. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Jackson, TN
- Active Since 09/19/2005
- Last Updated 06/07/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1003801796
Products in Payments
- Impella (Device) $2,545
- Repatha (Biological) $562.75
- AUSTEDO (Drug) $372.82
- LifeVest (Device) $369.39
- LEQVIO (Drug) $298.87
- COMET (Device) $221.31
- GENERAL STRUCTURAL HEART (Device) $194.73
- BRILINTA (Drug) $188.38
- AMVUTTRA (Drug) $174.19
- VERQUVO (Drug) $163.60
- ENTRESTO (Drug) $162.16
- SYNERGY ABLATION SYSTEM (Device) $161.05
- PROMUS EVEROLIMUS-ELUTING CORONARY STENT SYSTEM (Device) $154.83
- WATCHMAN FLX (Device) $154.73
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $151.42
- FARXIGA (Drug) $150.32
- BVA-100 (Device) $146.40
- XARELTO (Drug) $134.12
- ELIQUIS (Drug) $131.86
- WATCHMAN (Device) $127.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Jackson
Javed Butler, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $4.7M
Cardiovascular Disease $4.7M
Mr. Rajendra Mehta, Md, MD
Cardiovascular Disease — Payments: $358,105
Cardiovascular Disease $358,105
William Crowder, M.d, M.D
Cardiovascular Disease — Payments: $328,962
Cardiovascular Disease $328,962
Dr. Donny Stokes, Md, MD
Cardiovascular Disease — Payments: $207,711
Cardiovascular Disease $207,711
Dr. Adeyinka Agbetoyin, Md, MD
Cardiovascular Disease — Payments: $84,165
Cardiovascular Disease $84,165
Dr. Kenny Charn, M.d, M.D
Cardiovascular Disease — Payments: $60,472
Cardiovascular Disease $60,472